# A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

> **NCT00214864** · PHASE2 · COMPLETED · sponsor: **Cancer Research Network** · enrollment: 18 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** docetaxel, capecitabine

## Key facts

- **NCT ID:** NCT00214864
- **Lead sponsor:** Cancer Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214864, "A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00214864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*